Full-Time

Associate Director

Internal Communications

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$180k - $225kAnnually

Senior, Expert

San Carlos, CA, USA

This is a hybrid position, requiring some in-office days.

Category
Human Resources
People & HR
Required Skills
Communications
PowerPoint/Keynote/Slides

You match the following Revolution Medicines's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Minimum of [8] years of communications experience with [3] years minimum in a biotech/pharmaceutical company or at a PR/communications agency working with biotech/pharmaceutical clients.
  • Demonstrated ability to design and execute ideas from planning, developing, benchmarking, measuring, etc.
  • Executive presence with the ability to collaborate, lead, facilitate, influence, and organize across groups and at multiple levels of an organization.
  • Excellent organizational savvy with willingness and ability to work independently, think creatively, and shift gears depending on changing priorities and deadlines.
  • Strong creative ability, knowing how to use creative design effectively to enhance employee understanding of business strategies and engagement.
  • Ability to turn complex ideas into stories easily understood by a broad audience.
  • Independent self-starter able to write quickly under deadline with attention to detail and accuracy.
  • Exceptional presentation development skills and strong PowerPoint skills.
  • Strong interpersonal, writing, and verbal communication skills.
  • Ability to manage sensitive and confidential situations.
  • High energy and ability to create a positive working environment for colleagues and clients.
  • Proven ability to establish internal communication and change management best practices.
  • Bachelor's degree required, ideally in Communications/Public Relations or related field.
Responsibilities
  • Lead enhancement and implementation of RevMed’s internal communications strategy and work plan.
  • Support organization-wide initiatives and communications efforts, including: producing internal articles, orchestrating key employee events, and driving digital and multimedia storytelling that helps advance strategic goals.
  • Develop messages, content, and materials to support internal communications strategy, including all internal communication channels (email, intranet, town halls, employee events, digital signage, newsletters, videos, etc).
  • Develop and maintain editorial calendars to drive internal communications in line with company priorities and news flow.
  • Create and strengthen two-way channels for leadership/employee dialogue.
  • Drive communication and change management best practices, including educating the organization around communication norms/best practices.
  • Collaborate with HR to ensure employee communications are well coordinated and aligned with broader internal objectives and messaging.
  • In partnership with Patient Advocacy, use storytelling and events to bring our "tireless commitment to patients" into focus for employees.
  • Partner with IS to refresh and optimize the company’s intranet and other communications platforms.
  • Work closely with the Corporate Affairs team to ensure consistency in internal and external messaging, branding, and priorities for key milestones and data announcements.
  • Measure and report on internal communications activities and impact.
  • Serve as the trusted communications advisor.
Desired Qualifications
  • Master's degree preferred.

Revolution Medicines develops treatments specifically for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses solely on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective targeted therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity